Hormonally induced modulation in the phosphate metabolites of breast cancer: Analysis of in Vivo 31P MRS signals with a modified prony method

Magnetic Resonance in Medicine

Volumn 38, Issue 2, 1997, Pages 285-295

  Viti, V ^a   Ragona, R ^a   Guidoni, L ^a   Barone, P ^b   Furman, E ^c   Degani, H ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CNR   (Italy)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

In vivo NMR; Modified Prony method; Tamoxifen; Tumors

Indexed keywords

LAKES; MAMMALS; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

IN-VIVO; INORGANIC PHOSPHATES; PEAK IDENTIFICATION; PHOSPHOETHANOLAMINE; PRONY METHOD; SIGNAL INTENSITIES; SPATIALLY RESOLVED; TAMOXIFEN;

TUMORS;

ESTROGEN; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE; TAMOXIFEN;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; HORMONAL REGULATION; MOUSE; NONHUMAN; PHOSPHATE TRANSPORT; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE DIAGNOSIS; RELIABILITY; TUMOR REGRESSION;

EID: 0030836824     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910380219     Document Type: Article

References (36)

1. P. F. Daly, J. S. Cohen, MRS of tumors and potential in vivo clinical applications: a review. Cancer Res. 49, 770-779 (1989).
2. H. Degani, S. M. Ronen, E. Furman, Breast cancer-spectroscopy and imaging of cells and tumors, in "Magnetic Resonance in Physiology and Medicine," (R. Gillies ed.), pp. 329-351, Academic Press, Inc., New York, 1994.
3. S. L. Pelech, D. E. Vance, Regulation of phosphatidylcholine biosinthesis. Biochim. Biophys. Acta 779, 217-251 (1984).
4. W. Negedank, K. A. Padavic-Shaller, C. Li, J. Murphy-Boesch, R. Stoyanova, R. Krigel, R. J. Schilder, M. R. Smith, T. R. Brown, Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorous MRS. Cancer Res. 55, 3286-3294 (1995).
5. 31P NMR spectra of tumors. J. Magn. Reson. B 105, 137-146, (1994).
6. T. L. Ulrich, M. Ooe, Autoregressive and mixed autoregressive-moving average models, in "Nonlinear Methods of Spectral Analysis" (S. Haykin, ed.), Topics in Applied Physics, vol. 34, Springer-Verlag, Berlin, New York, 1979.
7. H. Barkhuijsen, R. De Beer, D. Van Ormondt, Aspects of the computational efficiency of LSPD. J. Magn. Reson. 64, 343-346 (1985).
8. S. Haykin, S. Kesler, Prediction error filtering and maximum-entropy spectral estimation, in "Nonlinear Methods of Spectral Analysis" (S, Haykin, ed.), Topics in Applied Physics, vol. 34, Springer-Verlag, Berlin, New York, 1979.
9. V. Viti, P. Barone, L. Guidoni, E. Massaro, Maximum entropy spectral analysis of 31P NMR signals from human cells. J. Magn. Reson. 67, 91-102 (1986).
10. L. L. Scharf, "Statistical Signal Procossing," Addison Wesley Publishing Co., New York, 1991.
11. J. Besag, P. Green, D. Higdon, K. Mengerson, Bayesan computation and stochastic systems, Stat. Sci. 10, 3-66 (1995).
12. G. L. Bretthorst, "Bayesan Spectrum Analysis and Parameter Estimation," Lectures Notes in Statistics, n. 48, Springer-Verlag, New York, 1988.
13. P. Barone, R. Ragona, Bayesan estimation of parameters of a damped sinusoidal model by a Markov chain Monte Carlo method, IEEE Trans. Signal Processing, in press.
14. P. Barone, R. Ragona, V. Viti, Variance estimation of damping factors by a Monte Carlo Markov chain method, in "Proc., SMR, 3rd Annual Meeting, Nice, 1995," p. 1945.
15. E. Furman, E. Rushkin, R. Margalit, P. Bendel, H. Degani, Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using NMR spectroscopy and imaging. J. Steroid Biochem. Molec. biol. 43, 189-195 (1992).
16. A. Connelly, C. Counsell, J. A. B. Lohman, R. J. Dudidge, Outer volume suppressed image related in vivo spectroscopy (OSIRIS), a high-sensitivity localization technique. J. Magn. Reson. 78, 519-525 (1988).
17. P. Barone, L. Guidoni, E. Massaro, V. Viti, Prony-Burg method for NMR spectral analysis. J. Magn. Reson. 73, 23-33 (1987).
18. J. C. Lindon, A. G. Ferrige, Digitization and data processing in Fourier transform NMR. Progr. NMR Spectrosc. 14, 27-66 (1980).
19. 31P NMR signals: I. Description of the method and application to simulated signals. Phys. Mod. Biol. 37, 2213-2230 (1992).
20. H. Degani, E. Furman, S. Fields, Magnetic resonance imaging and spectroscopy of MCF7 human breast cancer: pathophysiology and monitoring of treatment. Clin. Chim. Acta 228, 19-33 (1994).
21. 31P MRS. Cancer Res. 46, 4087-4090 (1986).
22. E. Furman, R. Margalit, P. Bendel, A. Horowitz, H. Degani, In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice. Cancer Commun. 3, 287-297 (1991).
23. T. C. Ng, A. W. Majors, S. Vijayakumar, N. J. Balsdwion, F. J. Thomas, I. Koumoundouros, M. L. Taylor, S. T. Grundfest, T. F. Meaney, R. Tubbs, K. H. Shin, Human neoplasma pH and response to radiation therapy: P-31 MR spectroscopy studies in situ. Radiology 170, 875-878 (1989).
24. P. L. Robitaille, P. A. Robitaille, G. Gordon Brown, Jr., George G. Brown, An analysis of the pH-dependent chemical shift behavior in phosphorous-containing metabolites. J. Magn. Reson. 92, 73-84 (1991).
25. W. T. Evanochko, T. C. Ng, J. D. Glickson, Application of in vivo NMR spectroscopy to oncology. Magn. Reson. Med. 1, 508-534 (1984).
26. 31P NMR study of the response of a murine mammary tumor to different doses of γ-radiation. Cancer Res. 46, 1427-1432 (1986).
27. 31P NMR for noninvasive evaluation of tumor metabolic status. Int. J. Radiat. Oncol. Biol. Phys. 12, 793-799 (1986).
28. 31P spectra with a Prony based method, in "Proc., SMR, 2nd Annual Meeting, San Francisco, 1994," p. 1316.
29. 31P spectra, in "Proc., ISMRM, 4th Annual Meeting, New York, 1996," p. 373.
30. 13C NMR studies of choline and ethanoiamine uptake. Biochim. Biophys. Acta 1138, 203-212 (1992).
31. S. M. Ronen, A. Stier, H. Degani, NMR studies of the lipid metabolism of T47D human breast cancer spheroids. FEBS Lett. 266, 147-149 (1990).
32. J. P. Freyer, K. A. Jarret, H. Linford, G. Moore, L. O. Sillerud, Alterations in phosphomonoesters NMR spectra of tumor spheroids during the development of cellular quiescence, in "Proc., SMRM, 12th Annual Meeting, New York, 1993," p. 256.
33. M. V. Miceli, G. S. Karczmar, D. J. Meyerhoff, M. D. Boska, B. Hubesch, J. Poole, G. B. Matson, F. Valon, L. Kaan, D. A. Newsome, P-31 NMR spectroscopy of human retinoblastoma cells: correlation with metabolic indices. Biochim. Biophys. Acta 970, 262-269 (1988).
34. J. L. Evelhoch, G. E. Soto, Z. Zhu, J. J. H. Ackerman, A general analysis of the error in NMR pH measurements, in "Proc., SMR, 2nd Annual Meeting, San Francisco 1994," p. 1342.
35. M. W. Weiner, P-31 spectroscopy study of response of superficial human tumors to therapy. Radiology 179, 149-153 (1991).
36. 31P MRS in situ. Magn. Reson. Med, 10, 125-134 (1989).